How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,453 results for

("physical activity" OR "physical exercise" OR "physical fitness") AND (leisure OR "active travel" OR "sports participation" OR housework OR mental) AND (statistics OR data) 〈=en

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. COVID-19 and violence against women. What the health sector/system can do

, and distancing can affect you and your family’s psychological well-being. • As much as possible, reduce sources of stress by: o Seeking information from reliable sources and reducing the time spent consuming news (1-2 times per day, rather than every hour). o Seeking support from family and friends via phone, email, text, etc. o Trying to maintain daily routines and make time for physical activity and sleep. o Using relaxation exercises (e.g. slow breathing, meditation, progressive muscle relaxation (...) violence by any perpetrator in their lifetime. Most of this is intimate partner violence. • Violence against women tends to increase during every type of emergency, including epidemics. Older women and women with disabilities are likely to have additional risks and needs. Women who are displaced, refugees, and living in conflict-affected areas are particularly vulnerable. • Although data are scarce, reports from China, the United Kingdom, the United States, and other countries suggest an increase

2020 WHO Coronavirus disease (COVID-19) Pandemic

102. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic Full Text available with Trip Pro

, but it is important to mention that these are not age-adjusted and 53% of cases had missing data on comorbidities. 4 In early retrospective analysis based on data from 138 patients in Wuhan, China, approximately 50% of patients with infection had one or more comorbidities. 5 Moreover, in patients admitted with a severe infection this proportion was as high as 72%. 5 It remains vague whether diabetes, hypertension and are causally linked or associated due to age. 6 However, an important message is the fact (...) of sputum) and long-term stability on contaminated surfaces. 19 is more stable on plastic and stainless steel than on copper and cardboard, and viable virus has been detected for up to 72 hours after application to these surfaces. 19 While the infectivity of is greater than that of influenza or SARS-coronavirus, more data are needed for accurate assessment. 20 Transmission occurs primarily by a combination of spread by droplet, and direct and indirect contact, and may possibly be airborne as well

2020 European Society of Cardiology

103. Coronavirus (COVID-19) infection and pregnancy

the COVID-19 pandemic. 9 13.5.20 1: Findings of UKOSS data included in the summaries on viral transmission, effects on the woman and effects on the fetus/neonate. Where this supersedes existing references because of higher quality research or larger numbers, it has been used to replace it. 9 13.5.20 1.3: Updated information on possibility of vertical transmission to state that there are serious limitations to the available evidence. 9 13.5.20 1.4: Updated with emerging evidence on increased risk from (...) or moderate cold-/flu-like symptoms. Cough, fever, shortness of breath, headache and anosmia are other relevant symptoms. The UKOSS study is the largest population-based cohort of pregnant women admitted to hospital with COVID-19 to date. At the time of the interim report, data were available for 427 pregnant women admitted 9to UK hospitals with confirmed SARS-CoV-2 infection between 1 March and 14 April 2020. The reported admission rate from UKOSS represents 4.9 admissions per 1,000 maternities (95% CI

2020 Royal College of Obstetricians and Gynaecologists

104. Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – tenth update

Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – ninth update, 23 April 2020 Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019- covid-19-pandemic-ninth-update. 5. Kellam P, Barclay W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. The Journal of general virology. 2020 May 20. 6. Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F (...) Bildung, Wissenschaft und Forschung; 2020 [10 June 2020]. Available from: https://www.bmbwf.gv.at/Themen/Forschung/Aktuelles/COVID-19-Studie.html. 12. University of Antwerp. Sero-epidemiology COVID-19 in Belgium 2020 Antwerp: University of Antwerp; 2020 [8 June 2020]. Available from: https://www.uantwerpen.be/en/research-groups/vaxinfectio/corona- research/sero-epidemiology-co/. 13. Institute of Health Information and Statistics of the Czech Republic (UZIS). Studie kolektivní imunity SARS- CoV-2-CZ

2020 European Centre for Disease Prevention and Control - Technical Guidance

105. Canadian guideline for Parkinson disease

sleep behaviour disorder can pre-date the diagnosis of Parkinson disease. PALLIATIVE CARE n The palliative care needs of people with Parkinson disease should be considered throughout all phases of the disease. n If the patient asks, the option of medical assistance in dying should be discussed. TREATMENT n Levodopa is the most eective medication and may be used early. n A regular exercise regimen begun early has proven benet. n Patients with possible diagnosis of Parkinson disease may benet from (...) the diagnosis of Parkinson disease. PALLIATIVE CARE n The palliative care needs of people with Parkinson disease should be considered throughout all phases of the disease. n If the patient asks, the option of medical assistance in dying should be discussed. TREATMENT n Levodopa is the most eective medication and may be used early. n A regular exercise regimen begun early has proven benet. n Patients with possible diagnosis of Parkinson disease may benet from a trial of dopamine replacement therapy to help

2019 CPG Infobase

106. Safe nurse staffing levels in acute hospitals

SET 47 3.1 BACKGROUND 47 3.1.1 The Belgian Nursing Minimum Data Set – version I 48 3.1.2 The B-NMDS version II 50 3.2 STUDY OBJECTIVE 52 3.3 METHODS 53 3.3.1 Data Selection 53 3.3.2 Measures 54 3.3.3 Statistical analysis and data presentation 58 3.4 STUDY POPULATION 60 3.4.1 Care Intensity per Patient Day 63 3.4.2 Patient turnover 68 3.4.3 Nursing Hours per Patient Day 69 3.4.4 Care Intensity relative to staffed nursing hours 71 3.4.5 Patient-to-nurse ratio 73 3.4.6 Proportion of Bachelor-prepared (...) -2019 113 5.1 BACKGROUND 113 4 Safe nurse staffing levels in acute hospitals KCE Report 325 5.2 STUDY OBJECTIVE 113 5.3 STUDY DESIGN 113 5.3.1 Participants 113 5.3.2 Survey methodology 113 5.3.3 Measures 114 5.3.4 Statistical analysis 115 5.3.5 General Data Protection Regulation (GDPR) 116 5.4 STUDY POPULATION 116 5.4.1 Participating hospitals 116 5.4.2 Participating nurses 117 5.5 RESULTS 119 5.5.1 Findings for the 2019 KCE study on nurse staffing 119 5.5.2 Evolution of nurse staffing and quality

2020 Belgian Health Care Knowledge Centre

107. Galcanezumab (migraine) - Benefit assessment according to §35a Social Code Book V

and for whom BSC is the only treatment option. These were shown both for adults with episodic migraine (4 to 14 migraine days/month) and for adults with chronic migraine, each in the outcome category of morbidity. 4 On the basis of the scientific data analysed, IQWiG draws conclusions on the (added) benefit or harm of an intervention for each patient-relevant outcome. Depending on the number of studies analysed, the certainty of their results, and the direction and statistical significance of treatment (...) assessment A19-28 Version 1.0 Galcanezumab (migraine) 27 June 2019 Institute for Quality and Efficiency in Health Care (IQWiG) - v - List of abbreviations Abbreviation Meaning ACT appropriate comparator therapy AE adverse event BSC best supportive care CI confidence interval EF Emotional Function G-BA Gemeinsamer Bundesausschuss (Federal Joint Committee) ICHD-3 International Classification of Headache Disorders, 3rd edition IPD individual patient data IQWiG Institut für Qualität und Wirtschaftlichkeit im

2019 Institute for Quality and Efficiency in Healthcare (IQWiG)

108. Deceased organ and tissue donation after medical assistance in dying and other conscious and competent donors: guidance for policy

that a person’s final wishes are honoured without placing their family, health care providers or potential recipients at risk of harm. References 1. e-Statistics on organ transplants, waiting lists and donors. Ottawa: Canadian Institute for Health Information; 2017. Available: www.cihi.ca/ en/e-statistics-on-organ-transplants-waiting-lists-and-donors (accessed 2018 Dec. 10). 2. Shemie SD, Baker AJ, Knoll G, et al. National recommendations for donation after cardiocirculatory death in Canada: donation after (...) on donation after circula- tory determination of death 2 ). Some practical recommendations were informed by limited clinical experience and some unpub- lished data, but were not evidence based. Management of competing interests All members of the guidance panel declared any competing interests before any presentations to panel members while plan- ning the meeting, and all presenters at the meeting declared their competing interests before their presentations. To manage competing interests further

2019 CPG Infobase

109. Organisation of maternity services in Belgium

), Cécile Camberlin (KCE), Stephan Devriese (KCE), Hilde Pincé (UZ Leuven), Christophe de Meester (KCE), Benoît Fricheteau (Institut Géographique National – Nationaal Geografisch Instituut), Carine Van de Voorde (KCE) Project facilitator: Nathalie Swartenbroekx (KCE) External experts: Leen Adriaenssens (GasthuisZusters Antwerpen (GZA)), Renilde Bastaens (Imeldaziekenhuis Bonheiden), Anne Batter (Vivalia IFAC Marche-en-Famenne), Yves Baukens (Europa Ziekenhuizen), Marion Boriau (Onze-Lieve (...) (Sint-Vincentiusziekenhuis Deinze), Sofie Verschoore (Jan Yperman Ziekenhuis Ieper), Lore Vanlangenakker (Ziekenhuis Oost-Limburg) Stakeholders: Sophie Alexander (Groupement des Gynécologues Obstétriciens de Langue Française de Belgique (GGOLFB)), Koen Balcaen (Beroepsorganisatie voor verpleegkundigen (NVKVV)) en Algemene Unie van Verpleegkundigen van België (AUVB)), Joëlle Belpaire (AVIQ), Natascha Beugnier (COCOM – GGC), Tom Bovyn (Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG)), Bernard

2020 Belgian Health Care Knowledge Centre

110. Towards integrated antenatal care for low-risk pregnancy

parents. Preparation to birth includes antenatal exercises, psychological adjustment to labour and birth, pain relief in labour, skin-to-skin contact with the newborn and (early) breastfeeding. 2, 4 Parenthood education may cover the psychological adjustment, the partner’s role and non-clinical interventions aiming to prepare parents to cope with mother and baby care and management of the daily life during the postpartum period. Baby care refers to (among others) feeding, hygiene, sleeping (...) ) pregnant women. Secondly, data of care consumption were analysed using quantitative methods such as descriptive and multivariate statistics (e.g. logistic regression). Finally, qualitative methods (i.e. workshops and face-to-face interviews) allowed to identify on the one hand the range of non-clinical interventions used in Belgium, and on the other hand, strengths and shortcomings in the Belgian organisation of ANC, as perceived by healthcare professionals and parents. The detailed description

2020 Belgian Health Care Knowledge Centre

111. Risk reduction and management of delirium

within view • bring in some familiar objects from home to the hospital to keep next to the bed side • if required, encourage the patient to eat and drink.23 9 | Provision of information If a patient develops delirium Explain to the patient and family/carers that delirium is a change in mental state that often starts suddenly but usually improves when the physical condition improves and the underlying cause gets better. Discuss treatment options and possible side effects with the patient and/or carer (...) syndrome characterized by concurrent disturbances of consciousness and attention, perception, thinking, memory, psychomotor behaviour, emotion, and the sleep-wake schedule. The duration is variable and the degree of severity ranges from mild to very severe.” 12 According to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), delirium is a disturbance in attention and awareness with an additional disturbance in cognition, not explained by another pre-existing, established

2019 SIGN

112. Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer

noted that the intention-to-treat results (hazard ratio [HR] 0.63; 95% confidence interval [CI] 0.47 to 0.86) suggested a statistically significant survival benefit for pembrolizumab compared with standard care. Median overall survival was 30.0 months for people on pembrolizumab and 14.2 months for those on standard care. The committee was aware that the trial protocol allowed people to switch from the standard care arm to have immunotherapy treatment on disease progression. The trial's data (...) The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance are at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals

2018 National Institute for Health and Clinical Excellence - Technology Appraisals

113. Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma

-of- rights).Y Y our responsibility our responsibility The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance are at the discretion of health professionals and their individual patients and do (...) ://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 21Contents Contents 1 Recommendations 4 2 Information about ixazomib 5 3 Committee discussion 6 New treatment option 6 Clinical management 7 Expected use of ixazomib 8 Comparators 9 Clinical effectiveness 9 Clinical evidence in the economic model 11 Extrapolating clinical trial data in the economic model 11 Health-related quality of life 13 Costs 14 End of life 14 Cancer Drugs Fund 15 Other factors 17 4 Implementation 18 5 Recommendations

2018 National Institute for Health and Clinical Excellence - Technology Appraisals

114. Intrabeam radiotherapy system for adjuvant treatment of early breast cancer

that there was no statistical reason for using a different method to assess whether Intrabeam is non-inferior to EBRT. L Local recurrence r ocal recurrence rates ates 4.8 The committee acknowledged that the rate of local recurrence in TARGIT-A was low in both treatment groups, and that longer follow-up of patients is needed to provide more long-term data and less uncertain results. The committee noted that the CI around the absolute difference in local recurrence at 5 years is wide, and that the upper end of the interval (...) group, but rather a shortfall of deaths in the Intrabeam group occurring by chance. The committee noted that the assessment group had compared the non-breast cancer mortality data from the EBRT group with the annual all-cause mortality probabilities obtained from the Office of National Statistics data and found that they were similar. The committee acknowledged that caution is needed when comparing international trial data (such as data from TARGIT-A) and country-specific data (such as data from

2018 National Institute for Health and Clinical Excellence - Technology Appraisals

115. Daratumumab monotherapy for treating relapsed and refractory multiple myeloma

The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance are at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals (...) of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 6 of 314 4 Committee discussion Committee discussion The appraisal committee reviewed the data available on the clinical and cost effectiveness of daratumumab, having considered evidence on the nature of multiple myeloma and the value placed on the benefits of daratumumab by people with the condition, those who represent them, and clinical experts. It also took into account the effective use of NHS resources. Nature

2018 National Institute for Health and Clinical Excellence - Technology Appraisals

116. Optimisation of RIZIV – INAMI lump sums for incontinence

A frail older person is aged over 65 with a combination of impaired physical activity, mobility, balance, muscle strength, motor processing, cognition, nutrition, and endurance (including feelings of fatigue and exhaustion). Frail people usually have multiple chronic medical conditions, take multiple medications, require care from others and assistance to perform some or all of the personal daily activities (bathing, dressing, toileting, mobility) and are often homebound or institutionalised (...) – FOR PERSONS WITH A HANDICAP 96 3.2.1 VAPH – Flemish community 96 3.2.2 AWIPH – AVIQ-Handicap – French Community 99 3.2.3 PHARE (Personne Handicapée Autonomie Recherchée) 101 3.2.4 German Community 101 3.3 FINANCIAL INTERVENTIONS BY COMPLEMENTARY INSURANCE OF SICKNESS FUNDS 101 3.4 OTHER COMPENSATIONS 101 4 INCONTINENCE IN BELGIUM: DATA OVERVIEW 102 4.1 INTRODUCTION 102 4.2 METHODS 102 4.2.1 MZG-RHM 2014: hospitalisations for incontinence 102 4 Incontinence KCE Report 304 4.2.2 EPS 2008-2015: sample

2020 Belgian Health Care Knowledge Centre

117. Obinutuzumab for untreated advanced follicular lymphoma

at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance are at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances (...) effects are more common with obinutuzumab than with rituximab. There are not enough data to know with certainty whether obinutuzumab increases life expectancy. The company's revised economic analyses focuses on higher-risk subgroups. Obinutuzumab costs more than branded rituximab and even more than the biosimilar versions of rituximab. However, using the preferred assumptions and the discounted prices for obinutuzumab and rituximab, the cost-effectiveness estimate for obinutuzumab plus chemotherapy

2018 National Institute for Health and Clinical Excellence - Technology Appraisals

118. Canadian guidelines on opioid use disorder among older adults

) . According to the latest NSDUH in 2016, 0 .8% of adults surveyed met Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria for OUD in the past year (Substance Abuse and Mental Health Services Administration (SAMHSA), 2017) . In contrast, the prevalence of OUD in older adults for prescription and illicit opioids in Canada has been difficult to estimate using current survey information . This may be due in part to the hesitancy of participants to disclose illegal activity (...) , completeness or currency of the contents of this publication. This publication is distributed with the understanding that neither the publisher nor any person involved in the creation of this publication is rendering professional advice. Physicians and other readers must determine the appropriate clinical care for each individual patient on the basis of all the clinical data available for the individual case. The publisher and every person involved in the creation of this publication disclaim any liability

2019 CPG Infobase

119. Health literacy: what lessons can be learned from the experiences of other countries?

– Service public francophone bruxellois, COCOF – Commission communautaire française), Karin Cormann (DGOV – Communauté germanophone), Maïté Cuvelier (Cultures et santé), Yves Dario (Koning Boudewijnstichting – Fondation Roi Baudouin), Valerie Fabri (UNMS - Union Nationale des mutualités Socialistes), Marleen Finoulst (Cebam, Gezondheid en Wetenschap), Siska Germonpré (NVSM – Nationaal Verbond van Socialistische Mutualiteiten), Claire Huyghebaert (UNML – Union Nationale des Mutualités Libres), Denis (...) DESIGN OF THE STUDY 22 2.3 IDENTIFICATION OF HEALTH LITERACY POLICIES AND INITIATIVES IN BELGIUM 22 2.4 TRANSVERSAL ANALYSIS OF FOREIGN HEALTH LITERACY POLICIES 23 2.4.1 Choice of the countries 23 2.4.2 Development of the analytical grid 23 2.4.3 Data collection method 23 2 Health literacy KCE Report 322 2.5 FORMULATION OF RECOMMENDATIONS FOR A BELGIAN ACTION PLAN 24 3 HEALTH LITERACY IN BELGIUM 24 3.1 THE LEVEL OF HEALTH LITERACY IN BELGIUM 24 3.1.1 2014 – Study of the Christian Health Insurance

2020 Belgian Health Care Knowledge Centre

120. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Full Text available with Trip Pro

patients or patients who might be refectory to initial therapy. 7. Treatment and Management POTS is a chronic condition with multiple proposed pathophysiologic mechanisms that contribute to the constellation of symptoms. There are currently no “cures” for POTS. The overarching goals of treatment should be to provide patient education, reduce symptoms, enhance quality of life, improve physical conditioning, and if possible, to achieve symptom remission. Treatment usually requires a combination (...) actuelle du syndrome de tachycardie orthostatique posturale (STOP) remonte à une petite série de cas de patients atteints d’une maladie subaiguë qui présentaient une tachycardie orthostatique excessive et une intolérance orthostatique, en l’absence d’une autre maladie reconnue. Selon les critères classiques, le STOP implique une tachycardie orthostatique excessive en l’absence d’hypotension orthostatique marquée, ainsi que des symptômes prédominants d’intolérance orthostatique, s’aggravant en position

2020 Canadian Cardiovascular Society

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>